Inactive Instrument
Mymetics Corporation Share Price Other OTC
Stocks
MYMX
US62856A1025
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 4L 4L 4L 3L 6L 4.14Cr 6L 42.69L 16.51L 2.04Cr 16.47L 16.11L 7.1Cr | P/E 2021 |
-1.86x | P/E 2022 | -1.77x |
|---|---|---|---|---|---|
| Enterprise Value | 7.21Cr 6.35Cr 5.85Cr 5.47Cr 10Cr 680.73Cr 10Cr 70Cr 27Cr 335.63Cr 27Cr 26Cr 1.17TCr | EV / Sales 2021 |
177x | EV / Sales 2022 | 78x |
| Free-Float |
99.88% | Yield 2021 * |
-
| Yield 2022 | - |
| 1 day | -10.24% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 58 | 19/11/2012 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -10.24% | +8.79% | - | - | 45 | |
| +4.43% | +0.21% | +60.07% | +115.25% | 5.29TCr | |
| +1.58% | +19.37% | +75.37% | +85.18% | 5.1TCr | |
| -0.23% | -2.41% | -14.36% | -16.00% | 2.28TCr | |
| +0.98% | +6.11% | -1.35% | +423.40% | 2.24TCr | |
| +2.03% | +10.85% | +30.31% | -12.32% | 1.7TCr | |
| +0.88% | +5.07% | +28.91% | -34.26% | 1.59TCr | |
| +0.68% | +1.51% | +16.43% | +168.03% | 1.33TCr | |
| +3.02% | +18.32% | +141.11% | +308.04% | 1.36TCr | |
| +0.79% | +2.79% | +80.29% | +116.18% | 1.18TCr | |
| Average | +0.36% | +4.59% | +46.31% | +128.17% | 2.45TCr | |
| Weighted average by Cap. | +1.96% | +4.49% | +48.56% | +120.53% |
| 2021 | 2022 | |
|---|---|---|
| Net sales | 4L 4L 3L 3L 6L 4.06Cr 6L 41.84L 16.18L 2Cr 16.15L 15.79L 6.96Cr | 10.28L 9L 8L 8L 14.6L 9.7Cr 14.88L 1Cr 38.69L 4.78Cr 38.6L 37.75L 17Cr |
| Net income | -47.3L -41.62L -38.34L -35.87L -67.16L -45Cr -68.48L -4.6Cr -1.78Cr -22Cr -1.78Cr -1.74Cr -77Cr | -48.05L -42.28L -38.94L -36.44L -68.23L -45Cr -69.57L -4.68Cr -1.81Cr -22Cr -1.8Cr -1.76Cr -78Cr |
| Net Debt | 6.71Cr 5.9Cr 5.44Cr 5.09Cr 9.53Cr 633.32Cr 9.72Cr 65Cr 25Cr 312.26Cr 25Cr 25Cr 1.09TCr | 7.17Cr 6.31Cr 5.81Cr 5.44Cr 10Cr 676.59Cr 10Cr 70Cr 27Cr 333.59Cr 27Cr 26Cr 1.16TCr |
Employees
-
